People · Operator

Gary Velasquez

Named in public records as an officer, director or promoter · active 2012–2019 · Other Health Care, Other Technology

2
Companies
2
Filings
$165.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Origin Holdings Inc.Other Health CareSeries D+$137.0M$253.1M2012
AIC Innovations Group, Inc.Other TechnologySeries B$28.7M$510.9M2019
Operator network

Gary Velasquez at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

John Drew · 3 companies · 1 sharedJohn DrewBrian Vandenberg · 2 companies · 1 sharedBrian VandenbergGrant Patrick · 1 companies · 1 sharedGrant PatrickJeffrey Kvam · 1 companies · 1 sharedJeffrey KvamJohn Spiller · 1 companies · 1 sharedJohn SpillerKenneth O'Keefe · 1 companies · 1 sharedKenneth O'KeefePatrick Grant · 1 companies · 1 sharedPatrick GrantMichael Liang · 9 companies · 1 sharedMichael LiangJeff Anderson · 8 companies · 1 sharedJeff AndersonVijay Lathi · 8 companies · 1 sharedVijay LathiRick Hawkins · 2 companies · 1 sharedRick HawkinsAdam Hanina · 1 companies · 1 sharedAdam HaninaGordon Kessler · 1 companies · 1 sharedGordon KesslerOrigin Holdings Inc. · $137.0M raisedOrigin Holdings Inc.AIC Innovations Group, Inc. · $28.7M raisedAIC Innovations Group…Gary VelasquezGV
Gary Velasquez Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Gary Velasquez on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Michael Liang19
Vijay Lathi18
Jeff Anderson18
John Drew13
Brian Vandenberg12
Rick Hawkins12
Jeffrey Kvam11
Patrick Grant11
John Spiller11
Gordon Kessler11
Adam Hanina11
Grant Patrick11
Kenneth O'Keefe11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.